Display options
Share it on

Exp Clin Cardiol. 2010;15(4):e96-9.

Hypokalemia and sudden cardiac death.

Experimental and clinical cardiology

Keld Kjeldsen

Affiliations

  1. Laboratory for Molecular Cardiology, Medical Department B, The Heart Centre, Copenhagen University Hospital (Rigshospitalet) and Danish National Research Foundation Centre for Cardiac Arrhythmia, University of Copenhagen, Copenhagen, Denmark.

PMID: 21264075 PMCID: PMC3016067

Abstract

Worldwide, approximately three million people suffer sudden cardiac death annually. These deaths often emerge from a complex interplay of substrates and triggers. Disturbed potassium homeostasis among heart cells is an example of such a trigger. Thus, hypokalemia and, also, more transient reductions in plasma potassium concentration are of importance. Hypokalemia is present in 7% to 17% of patients with cardiovascular disease. Furthermore, up to 20% of hospitalized patients and up to 40% of patients on diuretics suffer from hypokalemia. Importantly, inadequate management of hypokalemia was found in 24% of hospitalized patients. Hypokalemia is associated with increased risk of arrhythmia in patients with cardiovascular disease, as well as increased all-cause mortality, cardiovascular mortality and heart failure mortality by up to 10-fold. Long-term potassium homeostasis depends on renal potassium excretion. However, skeletal muscles play an important role in short-term potassium homeostasis, primarily because skeletal muscles contain the largest single pool of potassium in the body. Moreover, due to the large number of Na(+)/K(+) pumps and K(+) channels, the skeletal muscles possess a huge capacity for potassium exchange. In cardiovascular patients, hypokalemia is often caused by nonpotassium-sparing diuretics, insufficient potassium intake and a shift of potassium into stores by increased potassium uptake stimulated by catecholamines, beta-adrenoceptor agonists and insulin. Interestingly, drugs with a proven significant positive effect on mortality and morbidity rates in heart failure patients all increase plasma potassium concentration. Thus, it may prove beneficial to pay more attention to hypokalemia and to maintain plasma potassium levels in the upper normal range. The more at risk of fatal arrhythmia and sudden cardiac death a patient is, the more attention should be given to the potassium homeostasis.

Keywords: Arrhythmia; Hypokalemia; Na+/K+-ATPase; Potassium; Sudden cardiac death

References

  1. Am J Physiol Cell Physiol. 2004 Jul;287(1):C135-41 - PubMed
  2. Heart. 2003 Jan;89(1):31-5 - PubMed
  3. N Engl J Med. 1994 Jun 30;330(26):1852-7 - PubMed
  4. Br Heart J. 1983 Dec;50(6):525-9 - PubMed
  5. Kidney Int. 1990 Nov;38(5):869-72 - PubMed
  6. Acta Physiol Scand. 1984 Oct;122(2):103-17 - PubMed
  7. Br J Clin Pharmacol. 1987 Nov;24(5):645-53 - PubMed
  8. Lancet. 1990 Dec 8;336(8728):1396-9 - PubMed
  9. Diabetes. 2003 Jun;52(6):1469-74 - PubMed
  10. Pharmacotherapy. 2005 Sep;25(9):1266-70 - PubMed
  11. Int J Cardiol. 1991 Sep;32(3):331-8 - PubMed
  12. Hypertension. 2000 May;35(5):1025-30 - PubMed
  13. Scand J Clin Lab Invest. 1979 Apr;39(2):167-70 - PubMed
  14. Int J Cardiol. 2010 May 28;141(2):167-74 - PubMed
  15. J Appl Physiol (1985). 1995 Jan;78(1):172-8 - PubMed
  16. J Clin Invest. 1964 May;43:950-62 - PubMed
  17. Clin Sci (Lond). 1993 Sep;85(3):327-35 - PubMed
  18. Resuscitation. 2006 Jul;70(1):10-25 - PubMed
  19. Arch Intern Med. 2001 Apr 23;161(8):1089-95 - PubMed
  20. Am J Physiol. 1991 May;260(5 Pt 1):C958-64 - PubMed
  21. Br Heart J. 1987 Dec;58(6):572-82 - PubMed
  22. Am J Med. 1981 Apr;70(4):762-8 - PubMed
  23. N Engl J Med. 1999 Sep 2;341(10):709-17 - PubMed
  24. Acta Med Scand. 1988;224(6):531-7 - PubMed
  25. J Hypertens. 2001 Jul;19(7):1315-23 - PubMed
  26. Am Heart J. 1985 Nov;110(5):944-8 - PubMed
  27. Chest. 2004 Jun;125(6):2309-21 - PubMed
  28. Fundam Clin Pharmacol. 2010 Oct;24(5):535-7 - PubMed
  29. J Am Coll Cardiol. 2004 Jan 21;43(2):155-61 - PubMed
  30. Circulation. 2008 Oct 14;118(16):1643-50 - PubMed
  31. Fundam Clin Pharmacol. 2010 Oct;24(5):547-59 - PubMed
  32. Circulation. 1985 Apr;71(4):645-9 - PubMed
  33. Nature. 1981 Oct 29;293(5835):739-41 - PubMed
  34. Circ Heart Fail. 2010 Mar;3(2):253-60 - PubMed
  35. Metabolism. 1995 Jan;44(1):119-25 - PubMed
  36. Br J Clin Pharmacol. 1980 May;9(5):483-91 - PubMed
  37. Am J Physiol Renal Physiol. 2001 Jan;280(1):F95-F102 - PubMed
  38. Fundam Clin Pharmacol. 2010 Oct;24(5):595-605 - PubMed
  39. Medicine (Baltimore). 1985 Sep;64(5):323-32 - PubMed
  40. N Engl J Med. 1998 Aug 13;339(7):451-8 - PubMed
  41. Acta Med Scand Suppl. 1981;647:67-73 - PubMed
  42. Am Heart J. 1989 Sep;118(3):642-8 - PubMed
  43. Eur Heart J. 2007 Jun;28(11):1334-43 - PubMed
  44. Eur J Pharmacol. 1985 Jul 31;113(3):373-82 - PubMed
  45. Lancet. 2003 Sep 6;362(9386):777-81 - PubMed
  46. Br Med J (Clin Res Ed). 1988 Feb 13;296(6620):455-8 - PubMed
  47. J Physiol. 1977 Sep;270(2):383-414 - PubMed
  48. Br Med J (Clin Res Ed). 1981 Jun 13;282(6280):1932 - PubMed
  49. J Physiol. 1977 Feb;265(1):19-42 - PubMed
  50. Am J Med. 1982 Aug;73(2):155-9 - PubMed
  51. Am J Physiol Cell Physiol. 2006 May;290(5):C1355-63 - PubMed
  52. J Clin Invest. 1930 Apr;8(3):325-35 - PubMed

Publication Types